|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW |
A Karagiannis, Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
K Tziomalos, Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
A Kakafika, Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
V Athyros, Second Propedeutic Department of Internal Medicine, Aristorle University of Thessaloniki, Thessaloniki, Greece
F Harsoulis, Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
D Mikhailidis, Department of Clinical Biochemistry (Vascular Prevention Clinic), Royal Free University, London, United Kingdom
Correspondence: Asterios Karagiannis, Email: astkar{at}med.auth.gr
Abstract
Primary aldosteronism (PA) and in particular its 2 commonest subtypes [i.e. idiopathic hyperaldosteronism (IHA) and aldosterone-producing adenoma (APA)] have been recognised as the most common cause of secondary hypertension. While "conservative" medical treatment with aldosterone receptor antagonists is the therapeutic approach of choice in controlling blood pressure (BP) in patients with PA due to IHA, the more invasive (laparoscopic) adrenalectomy seems to be the most suitable therapy for patients with APA. In this review we focus on the medical approach for the management of APA in cases where surgical excision of the adrenal is not possible.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |